
生物醫藥技術全國重點實驗室
(香港大學)
State Key Laboratory of Pharmaceutical Biotechnology
(The University of Hong Kong)


Field of Research
Clinical and basic research of metabolic cardiovascular diseases
Biography
Dr. Bingchao Qi is currently a postdoctoral fellow in the Department of Medicine, The University of Hong Kong. He received his Bachelor of Medicine from the Fourth Military Medical University in 2017, and obtained his Ph.D. in Clinical Medicine from the Air Force Medical University in 2023. In 2025, he was awarded the Hong Kong Scholars Program. His research focuses on the roles and mechanisms of metabolite‑mediated novel protein acylation modifications in metabolic cardiovascular diseases.
Publications
(1) Bingchao Qi; Linjie He; Ya Zhao; Ling Zhang; Yuanfang He; Jun Li; Congye Li; Bo Zhang; Qichao Huang; Jinliang Xing; Fei Li; Yan Li; Lele Ji; Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis, Diabetologia, 2020, 63(5): 1072-1087
(2) Bingchao Qi; Liqiang Song; Lang Hu; Dong Guo; Gaotong Ren; Tingwei Peng; Mingchuan Liu; Yexian Fang; Chunyu Li; Mingming Zhang; Yan Li; Cardiac-specific overexpression of Ndufs1 ameliorates cardiac dysfunction after myocardial infarction by alleviating mitochondrial dysfunction and apoptosis, Experimental and Molecular Medicine, 2022, 54(7): 946-960
(3) Bingchao Qi; Tiantian Li; Haixia Luo; Lang Hu; Renqian Feng; Di Wang; Tingwei Peng; Gaotong Ren; Dong Guo; Mingchuan Liu; Qiuhe Wang; Mingming Zhang; Yan Li; Reticulon 3 deficiency ameliorates post-myocardial infarction heart failure by alleviating mitochondrial dysfunction and inflammation, Medcomm, 2024, 5(3)
Grants
(1) National Natural Science Foundation of China, Young Fund (PI), 2024
(2) Hong Kong Scholars Program, 2025
(3) Shaanxi Province University Outstanding Young Talent Support Program, 2025
